Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol + granisetron with or without dexamethasone for prevention of postoperative nausea and vomiting in gynecologic surgery
jRCTs051260129Phase 2Recruiting
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of propofol, granisetron and dexamethasone in postoperative nausea and vomiting (PONV) (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting within 24 hours after surgery. Started Oct 2026; status: recruiting.
02
Drugs
propofolgranisetrondexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on jRCTs051260129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051260129.